Permissive hypotension and desmopressin enhance clot formation

Journal of Trauma - Injury, Infection and Critical Care

Volumn 68, Issue 1, 2010, Pages 42-50

  Rezende Neto, Joao B ^a   Rizoli, Sandro B ^b   Andrade, Marcus V ^a   Ribeiro, Daniel D ^a   Lisboa, Thiago A ^a   Camargos, Elizabeth R ^a   Martins, Paula ^a   Cunha Melo, Jose R ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Desmopressin (DDAVP); Hemorrhage model; Resuscitation

Indexed keywords

DESMOPRESSIN; FIBRIN; HEMOGLOBIN; THROMBOPLASTIN; ARGIPRESSIN[1 DEAMINO]; HEMOSTATIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA INJURY; ARTERIAL GAS; ARTICLE; BLEEDING; BLOOD CELL COUNT; BLOOD CLOTTING; BLOOD PRESSURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLUID RESUSCITATION; HEMATOCRIT; HEMODYNAMICS; HEMORRHAGIC SHOCK; HEMOSTASIS; HYPOTENSION; LABORATORY TEST; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PH; PRIORITY JOURNAL; RABBIT; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOPLASTIN TIME; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BLOOD; DRUG EFFECT; METHODOLOGY; PATHOPHYSIOLOGY; RESUSCITATION; THROMBOELASTOGRAPHY;

ANIMALS; BLOOD COAGULATION; BLOOD PRESSURE; DEAMINO ARGININE VASOPRESSIN; HEMORRHAGE; HEMOSTATICS; HYPOTENSION; MALE; RABBITS; RESUSCITATION; SHOCK, HEMORRHAGIC; THROMBELASTOGRAPHY;

EID: 75649112640     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181c66393     Document Type: Article

References (46)

1. Bickell WH. Are victims of injury sometimes victimized by attempts at fluid resuscitation? Ann Emerg Med. 1993;22:225-226.
2. Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008;65:748-754.
3. Hoyt DB, Dutton RP, Hauser CJ, et al. Management of coagulopathy in the patients with multiple injuries: results from an international survey of clinical practice. J Trauma. 2008;65:755-765.
4. Kauvar DS, Wade CE. The epidemiology and modern management of traumatic hemorrhage: US and international perspectives. Crit Care. 2005;9(suppl 5):S1-S9.
5. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma. 1995;38:185-193.
6. Committee on Trauma. Advanced Trauma Life Support Student Manual. 8th ed. Chicago, IL: American College of Surgeons; 2008:55-84.
7. National Institute for Clinical Excellence. Appraisal consultation document on pre-hospital initiation of fluid replacement therapy in trauma web site. October 2, 2003. Available at: http://www.nice.org.uk/ page.aspx?o-85337. Accessed December 10, 2008.
8. Beekley AC. Damage control resuscitation: a sensible approach to the exsanguinating surgical patient. Crit Care Med. 2008;36:S267-S274.
9. Bickell WH, Wall MJ Jr, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. New Engl J Med. 1994;311:1105-1109.
10. Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007; 62:307-310.
11. MacLeod J, Lynn M, McKenney MG, Jeroukhimov I, Cohn SM. Predictors of mortality in trauma patients. Am Surg. 2004;70:805-810.
12. Mattox KL. Permissive hypotension. [TRAUMA.ORG Web site]. January 1, 2003. Available at: http://www.trauma.org/archive/resus/ permhypoeditorial.html. Accessed December 1, 2008.
13. Roberts I, Evans P, Bunn F, Kwan I, Crowhurst E. Is the normalization of blood pressure in bleeding trauma patients harmful? Lancet. 2001; 357:385-387. (Pubitemid 32128551)
14. Tremblay LN, Rizoli SB, Brenneman FD. Advances in fluid resuscitation of hemorrhagic shock. Can J Surg. 2001;44:172-179.
15. Mapstone J, Roberts I, Evans P. Fluid resuscitation strategies: a systematic review of animal trials. J Trauma. 2003;55:571-589.
16. Parr MJ, Bouillon B, Brohi K, et al. Traumatic coagulopathy: where are the good models? J Trauma. 2008;65:766-771.
17. Dutton RP, Mackenzie CF, Scalea TM. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma. 2002;52: 1141-1146.
18. Turner J, Nicholl J, Webber L, Cox H, Dixon S, Yates D. A randomized control trial of pre-hospital intravenous fluid replacement therapy in serious trauma. Health Technol Assess. 2000;4:1-57.
19. Maegele M, Lefering R, Yucel M, et al; AG Polytrauma of the German Trauma Society (DGU). Early coagulopathy in multiple injury: an analysis from the German trauma registry on 8724 patients. Injury. 2007;38:298-304.
20. Boffard KD, Riou B, Warren B, et al; NovoSeven Trauma Study Group. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebocontrolled, double-blind clinical trials. J Trauma. 2005;59:8-15.
21. Perkins JG, Schreiber MA, Wade CE, Holcomb JB. Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion. J Trauma. 2007;62:1095-1099.
22. Rizoli SB, Boffard KD, Riou B, et al; NovoSeven Trauma Study Group. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials. Crit Care. 2006;10:R178.
23. Rizoli SB, Nascimento B Jr, Osman F, et al. Recombinant activated coagulation factor VII and bleeding trauma patients. J Trauma. 2006; 61:1419-1425.
24. Spinella PC, Perkins JG, McLaughlin DF, et al. The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion. J Trauma. 2008;64:286-294.
25. Barnhart MI, Chen S, Lusher JM. DDAVP: does the drug have a direct effect on vessel wall. Thromb Res. 1983;31:239-253.
26. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood. 1997;90:2515-2521.
27. Sakariassen KS, Cattaneo M, vd Berg A, Ruggeri ZM, Mannucci PM, Sixma JJ. DDAVP enhances platelet adherence and platelet aggregation growth on human artery subendothelium. Blood. 1984;64:229-236.
28. Canon WB, Fraser J, Cowell EM. The preventive treatment of wound shock. JAMA. 1918;70:618-621.
29. Beecher HK. The management of traumatic shock. In: Beecher HK, ed. Resuscitation and Anaesthesia for Wounded Men. Springfield, IL: Charles C Thomas; 1949:123-127.
30. Mahdy AM, Webster NR. Perioperative systemic haemostatic agents. Br J Anaesth. 2004;93:842-858.
31. Erstad BL. Systemic hemostatic medications for reducing surgical blood loss. Ann Pharmacother. 2001;35:925-934.
32. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta analyses using perioperative blood transfusion as the outcome. The International Study of Perioperative Transfusion (ISPOT) investigators. Anesth Analg. 1997;85:1258-1267.
33. Mongan PD, Hosking MP. The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. Anesthesiology. 1992;77: 38-46.
34. Butler KD, Dolan SL, Talbot MD, Wallis RB. Factor VIII and DDAVP reverse the effect of recombinant desulphatohirudin (CGP 39393) on bleeding in the rat. Blood Coagul Fibrinolysis. 1993;4:459-464.
35. Wingate GF, Lewis VL Jr, Green D, Wiedrich TA, Koenig WJ. Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plast Reconstr Surg. 1992;89:279-282.
36. Ryan KL, Cortez DS, Dick EJ Jr, Pusateri AE. Efficacy of FDAapproved hemostatic drugs to improve survival and reduce bleeding in rat models of uncontrolled hemorrhage. Resuscitation. 2006;70:133-144.
37. Kheirabadi BS, Crissey JM, Deguzman R, Holcomb JB. In vivo bleeding time and in vitro thromboelastography measurements are better indicators of dilutional hypothermic coagulopathy than prothrombin time. J Trauma. 2007;62:1359-1361.
38. Martini WZ, Cortez DS, Dubick MA, Park MS, Holcomb JB. Thromboelastograhy is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs. J Trauma. 2008;65:535-543.
39. Al Dieri R, Peyvandi F, Santagostino E, et al. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost. 2002;88:576-582.
40. Siller-Matula JM, Plasenzotti R, Spiel A, Quehenberger P, Jilma B. Interspecies differences in coagulation profile. Thromb Haemost. 2008; 100:397-404.
41. Roudsari BS, Nathens AB, Arreola-Risa C, et al. Emergency Medical Service (EMS) systems in developed and developing countries. Injury. 2007;38:1001-1013.
42. Sampalis JS, Tamin H, Denis R, et al. Ineffectiveness of on-site lines: is prehospital time the culprit? J Trauma. 1997;43:608-615.
43. Majde JA. Animal models for hemorrhage and resuscitation research. J Trauma. 2003;54:S100-S105.
44. Soucy DM, Rude M, Hsia WC, Hagedorn FN, Illner H, Shires GT. The effects of varying fluid volume and rate of resuscitation during uncontrolled hemorrhage. J Trauma. 1999;46:209-215.
45. Hirshberg A, Hoyt DB, Mattox KL. Timing of fluid resuscitation shapes the hemodynamic response to uncontrolled hemorrhage: analysis using dynamic modeling. J Trauma. 2006;60:1221-1227.
46. Cayten CG, Longmore W, Kuehl A. BLS versus ALS for trauma in an urban setting. Ann Emerg Med. 1986;15:626.